Drugs / Bacillus of Calmette and Guerin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04449926 | Nov 2020 → Dec 2021 | Alzheimer disease | Mindful Diagnostics and Therapeutics, LLC | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bacillus of Calmette and Guerin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04449926 ↗ |
| Known as | BCG | “Bacillus of Calmette and Guerin (BCG)” NCT04449926 ↗ |
| Modality | Vaccine | “BCG vaccination, the most widely used vaccination in the world” NCT04449926 ↗ |